SCHEMBL24739683

SCHEMBL24739683

Cc1ccc(-c2ccc3c4ccccc4n(-c4cc(-c5ccccc5C#N)c(-n5c6ccccc6c6ccc(-c7ccc(C)cc7C)cc65)cn4)c3c2)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.37
GABRG2 P18507 4/20 0.37
GABRB3 P28472 4/20 0.37
GABRA2 P47869 4/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
TRPA1 O75762 1/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2B Q13224 2/20 0.35
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
CYP1A2 P05177 5/20 0.33
CYP3A4 P08684 5/20 0.33
ALDH1A1 P00352 4/20 0.33
HSD17B10 Q99714 3/20 0.33
HPGD P15428 3/20 0.33
KDM4E B2RXH2 3/20 0.33
NR3C1 P04150 1/20 0.33
TP53 P04637 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24738591 0.97 GABRA1 (0.38) GABRA1GABRG2GABRB3GABRA2GABRA5
SCHEMBL24739684 0.95 GABRA1 (0.37) GABRA1GABRG2GABRB3GABRA2GABRA5
SCHEMBL21928632 0.92 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRA2GABRA5
SCHEMBL21931795 0.92 AR (0.38) GABRA1GABRG2GABRB3GABRA2GABRA5
SCHEMBL21929035 0.91 GABRA1 (0.35) GABRA1GABRG2GABRB3GABRA2GABRA5
SCHEMBL21929058 0.90 GABRA1 (0.37) GABRA1GABRG2GABRB3GABRA2GABRA5
SCHEMBL21928482 0.90 TRPA1 (0.34) GABRA1GABRG2GABRB3GABRA2GABRA5
SCHEMBL21929296 0.89 AR (0.40) GABRA1GABRG2GABRB3GABRA2GABRA5
SCHEMBL21931789 0.89 TRPA1 (0.41) GABRA1GABRG2GABRB3GABRA2GABRA5
SCHEMBL21929299 0.89 GABRA1 (0.40) GABRA1GABRG2GABRB3GABRA2GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA GABRA1 1888/4885GABRG2 1307/4885GABRB3 1759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.